Clinical Microbiology

The Department of Clinical Microbiology focuses on infectious diseases caused by pathogenic microorganisms, particularly bacteria. We aim to contribute to the prevention, diagnosis, and treatment of these diseases through molecular studies of pathogenic mechanisms and the development of advanced diagnostic methods.

In response to growing public health concerns such as antimicrobial-resistant bacteria and emerging/re-emerging infections, our research centers on the following areas:

• Elucidation of the Pathogenic Mechanisms of Bacterial Toxins
  We clarify how bacterial toxins contribute to pathogenesis and disease progression, forming the basis for new diagnostic and therapeutic strategies.
• Surveillance and Molecular Epidemiological Analysis of Antimicrobial-Resistant Bacteria
  Using genetic and molecular epidemiological approaches, we study drug-resistant bacteria isolated from clinical settings to support public health risk assessment and countermeasures.
• Molecular Analysis of Host Innate Immune and Stress Responses
  We investigate the host immune defense mechanisms and inflammatory responses at the molecular level, providing an immunological perspective on infection control.
• Development of Rapid and Highly Sensitive Diagnostic Methods for Pathogens and Virulence Factors
  To enable prompt diagnosis in clinical settings, we develop novel pathogen detection methods using molecular biology techniques.

Through these research activities, we conduct comprehensive studies on infectious diseases, from basic science to clinical applications, aiming to develop technologies and knowledge that are useful in medical practice. We are also committed to fostering professionals who can contribute to the advancement of public health and clinical laboratory science.